Daré Bioscience is a clinical-stage biopharmaceutical firm based in San Diego, which is dedicated to developing and marketing products for women's health in the United States. It specializes in contraception, fertility, and sexual and vaginal health therapies, with XACIATO being among the drugs already available in the market for the treatment of bacterial vaginosis in females aged 12 years and above. The company's other products in advanced clinical development include Ovaprene for vaginal contraception, Sildenafil Cream for the treatment of female sexual arousal disorder, and DARE-HRT1 for the treatment of hormone therapy's vasomotor symptoms, among others.